Conceivable Life Sciences

New York, NY · Founded 2022 · Privately Held (backing)

Developer of a fully automated AI-powered IVF lab designed to improve precision, quality, and scalability in fertility treatments. Conceivable Life Sciences is based in New York, NY and was founded in 2022. It was valued at $145 million at its early-stage round in Aug 2025, the last priced event on record. It has raised $88.5 million across 3 recorded rounds; the latest was a $30.5 million early-stage round in Aug 2025.

PMV mark · valuation
$145.0M
Oct 2026
Priced at
its early-stage round
Aug 2025
Total raised
$88.5M
Last round
Early Stage VC
Aug 2025
What is Conceivable Life Sciences worth?
$145.0MPrivateMarketView mark · Oct 2026

Valued at $145.0M at its early-stage round, Aug 2025. Nothing has traded since.

Free account
More of Conceivable Life Sciences with a free account
  • ·The complete investor list: 13 names
  • ·Watch Conceivable Life Sciences: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Conceivable Life Sciences funding history

3 rounds
DateRoundRaisedPost-money
Aug 2025Early Stage VC$30.5M▮
Nov 2024Debt$16.0M▮
Jul 2023Early Stage VC$17.0M▮
Unlock post-money valuations

Membership and data by Private Market View

Conceivable Life Sciences valuation

Conceivable Life Sciences was valued at $145 million at its early-stage round in Aug 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Conceivable Life Sciences raised?

Conceivable Life Sciences has raised $88.5 million across 3 recorded rounds since 2023. The largest was a $30.5 million early-stage round in Aug 2025.

Conceivable Life Sciences has filed 4 Form Ds with the SEC since 2023, most recently in Sep 2025 ($30.5 million sold to 20 investors).

How Conceivable Life Sciences's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Conceivable Life Sciences, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about Conceivable Life Sciences

What is Conceivable Life Sciences worth?
Conceivable Life Sciences is valued at $145.0M as of Oct 2026. Valued at $145.0M at its early-stage round, Aug 2025. Nothing has traded since.
How much has Conceivable Life Sciences raised?
Conceivable Life Sciences has raised $88.5M in total funding across 3 recorded rounds.
When did Conceivable Life Sciences last raise?
Conceivable Life Sciences last raised in Aug 2025 (Early Stage VC), raising $30.5M.